percent of americans on glp 1 Big shift in U.S. health! A new Gallup poll shows 11% now taking GLP-1 drugs, coinciding with obesity rates dropping to 36.4% (down from 39.9% in 2022). Promising progress in US adult obesity rate drops

Sleep becomes deeper and more restorative, and patients who train report less soreness and faster turnaround between sessions

Aim for 2535g of fiber daily

safety disclaimers are clear on the website

The Precision Peptide Genetic Test reveals predispositions in pathways related to metabolic health and nutrient processing

In clinical trials, people taking Wegovy (injectable semaglutide) lost an average of about 19% of their body weight, while Zepbound (tirzepatide) produced average weight loss exceeding 20% in some studies

Topical percentage conversions Understanding what topical percentages mean helps compare products and DIY formulations